The population pharmacokinetic profile of vancomycin (VCM) in Japanese
pediatric patients infected with methicillin-resistant Staphylococcus
aureus was analyzed using 181 samples of serum concentration data fro
m 49 patients obtained in routine drug monitoring. The one-compartment
linear model was adopted, where the VCM clearance (CL) and the distri
bution volume (V-d) were correlated with covariates such as postnatal
age (AGE) and body weight (BWT). The population pharmacokinetic analys
is program NONMEM with the first-order conditional estimation method w
as used. The results showed that the population mean clearance normali
zed by BWT increases with AGE up to 1 year of age [CL(L/hour per kg) =
0.119 +/- 0.0619 . (AGE - 1)] and decreases with age over 1 year old
[CL(L/hour per kg) = 0.119 +/- 0.00508 . (1 - AGE)]. The population me
an of the distribution volume normalized by BWT was independent of AGE
(V-d (L/kg) = 0.522). The interindividual variability of CL was 39.6%
, and that of V-d was 18.8%. The intraindividual, residual variability
was 34.6%. These results were compared with those in other articles,
and a guideline for dosage adjustment in VCM therapy is discussed.